<DOC>
	<DOCNO>NCT01966783</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety budesonide suppository treatment acute ulcerative proctitis .</brief_summary>
	<brief_title>Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy Acute Ulcerative Proctitis</brief_title>
	<detailed_description />
	<mesh_term>Proctitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Active ulcerative proctitis Diagnosis confirm endoscopy Established disease new diagnosis Crohn 's disease , indeterminate colitis , ischemic colitis , radiation colitis , diverticular assoc . colitis , microscopic colitis Presence proctitis different origin Prior bowel resection Presence symptomatic organic disease gastrointestinal tract Asthma , tuberculosis , cardiovascular disease , diabetes mellitus , osteoporosis , active peptic ulcer disease , glaucoma , cataract , infection careful medical monitoring ensure Local intestinal infection Abnormal hepatic renal function Oral/rectal/intravenous corticosteroid therapy Existing intend pregnancy breastfeed Participation another clinical trial within last 30 day , simultaneous participation another clinical trial , previous participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>